Latest news
22-01-2025 - Late February Deadline for Fondation Maladies Rares/argenx Antibody Targets Research Prize
Fondation Maladies Rares (Foundation for Rare Diseases) is a non-profit umbrella organisation created in 2012. Its two main objectives are to understand rare diseases to facilitate their diagnosis and to accelerate the development of new treatments and to improve the lives of people with rare diseases and their families. argenx is a global biopharmaceutical company, headquartered in the Netherlands, with a mission to improve the lives of people living with severe autoimmune disease. The company designs and develops a range of therapies, based on advanced technology for the optimisation of therapeutic antibodies, to treat severe autoimmune diseases.
[...]